Evidence map›Paper›PMID 29922292›Full record

ArticleFrontiers in immunology2018

Promyelocytic Leukemia Restricts Enterovirus 71 Replication by Inhibiting Autophagy.

Deyan Chen, Chunhong Feng, Xiaoyan Tian, Nan Zheng, Zhiwei Wu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Deyan ChenCenter for Public Health Research, Medical School, Nanjing University, Nanjing, China.
Chunhong FengCenter for Public Health Research, Medical School, Nanjing University, Nanjing, China.
Xiaoyan TianCenter for Public Health Research, Medical School, Nanjing University, Nanjing, China.
Nan ZhengCenter for Public Health Research, Medical School, Nanjing University, Nanjing, China.
Zhiwei WuCenter for Public Health Research, Medical School, Nanjing University, Nanjing, China.
Nanjing Medical University · CNNanjing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The promyelocytic leukemia (PML) protein, also known as TRIM19, functions as a major organizer of PML nuclear bodies (NBs) in most mammalian cells and plays important roles in antiviral activities against both DNA and RNA viruses. In this study, we found that the downregulation of PML rendered HeLa cells more susceptible to infection by enterovirus 71 (EV71), and the overexpression of the PMLIII or PMLIV isoforms inhibited viral protein expression and resulted in viral titers that were 2-3 log units lower than those in the control. Using short interfering RNAs, the downregulation of either the PMLIII or PMLIV isoform increased both viral protein VP1 expression and viral production. The PML repression of EV71 replication was partially mediated by the inhibition of autophagy, and PML deficiency triggered autophagy. Furthermore, the EV71 infection resulted in a reduction in PML independent of the proteasome pathway. Instead, PML degradation was mediated by virus protease 3C

Indexed as

AutophagyVirus ReplicationEnterovirus A, HumanEnterovirus InfectionsGene ExpressionHeLa CellsHost-Pathogen InteractionsHumansInterferon-betaLeukemia, Promyelocytic, AcutePromyelocytic Leukemia ProteinProteasome Endopeptidase ComplexProtein IsoformsRNA InterferenceInterferon-betaPromyelocytic Leukemia ProteinProteasome Endopeptidase ComplexProtein Isoforms3Cproautophagyenterovirus 71interferon-βpromyelocytic leukemiapromyelocytic leukemia protein-nuclear bodies

Identifiers

PMID29922292
PMCPMC5996053
OpenAlexW2803584160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.